Date published: 2025-10-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

MFSD8 Activators

MFSD8 activators belong to a category of chemical agents that interact with the Major Facilitator Superfamily Domain containing 8 (MFSD8) protein. MFSD8, a member of the larger Major Facilitator Superfamily (MFS), is a transmembrane protein that typically functions in transport processes across cellular membranes. The MFS proteins are characterized by their ability to facilitate the movement of a variety of substrates across cell membranes, including ions, sugars, amino acids, and other small molecules, utilizing diverse mechanisms such as uniport, symport, or antiport. MFSD8 activators, therefore, are chemicals designed to modulate the activity of the MFSD8 protein, influencing its natural role in the transport mechanisms within the cells.

The interaction between MFSD8 activators and the MFSD8 protein can modulate its function at a molecular level. These activators may bind to specific sites on the MFSD8 protein, inducing conformational changes that can enhance its transport activity. Since the MFSD8 protein is embedded in the cellular membrane, activators often possess certain physicochemical properties that enable them to traverse the hydrophobic lipid bilayer to reach their target. This interaction is highly specific, as the chemical structure of an activator determines its affinity and efficacy in modulating the MFSD8 protein function. The structure-activity relationship (SAR) is a critical aspect in the development and understanding of MFSD8 activators, providing insights into how different chemical modifications can impact the interaction with the protein and its subsequent activation.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$96.00
$250.00
$750.00
$1428.00
280
(6)

Bafilomycin A1 inhibits V-ATPase, which prevents acidification of lysosomes. This inhibition could indirectly lead to changes in lysosomal activity, potentially affecting the function of MFSD8.

U 18666A

3039-71-2sc-203306
sc-203306A
10 mg
50 mg
$140.00
$500.00
2
(1)

U18666A inhibits cholesterol trafficking and can lead to the accumulation of cholesterol in lysosomes. This might influence lysosomal membrane composition and function, thereby potentially enhancing MFSD8 activity.